Podcaster Bobbi Althoff used TikTok to describe side effects from a recent Botox treatment for jaw pain, reviving debate over off-label injections for temporomandibular issues. The video, posted this week, drew quick attention as Althoff said she proceeded despite past concerns.
She said the treatment targeted her jaw, a common site for injections meant to ease clenching and grinding. She also noted a prior bad experience that made her cautious this time. Her comments reflect growing interest in medical uses of cosmetic procedures and the risks patients face.
What She Shared
Bobbi Althoff posted a TikTok explaining the side effects of a recent Botox treatment intended to help with her jaw issues. The podcaster told viewers that she was wary of the injections after a bad experience a couple of years ago.
Althoff did not present the treatment as cosmetic. She framed it as an attempt to manage pain and tension. That distinction matters because the use of botulinum toxin for jaw disorders is considered off-label in the United States.
Background: Botox and Jaw Pain
Botox is approved by the U.S. Food and Drug Administration for several medical conditions and for cosmetic uses such as frown lines and crow’s feet. It is not approved for temporomandibular disorders, often called TMD.
Doctors sometimes inject the masseter or temporalis muscles to reduce clenching. Patients often seek relief from headaches, jaw soreness, or enamel wear. Research shows mixed outcomes, and dosing and technique vary by clinician.
Common short-term side effects include bruising, tenderness, headache, and chewing fatigue. Less common issues can include smile asymmetry or changes in facial contour if nearby muscles are affected. The FDA also warns about the rare risk of toxin spread beyond the injection site.
Reactions and Patient Concerns
Althoff’s caution mirrors what many patients report before trying injections for jaw problems. People often balance pain relief hopes with fear of side effects and cost. Some patients describe meaningful relief that lasts three to four months. Others report minimal benefit or unwanted changes in chewing strength.
- Relief can vary widely based on dose and muscle anatomy.
- Side effects often fade as the drug wears off over weeks to months.
- Repeat treatments may be needed to maintain results.
Patient education remains uneven. Some arrive believing jaw injections are routine. Others assume they are unsafe. Providers emphasize consultation, conservative dosing, and a plan that includes dental care, night guards, or physical therapy when appropriate.
Expert View: Off-Label Use and Safety
Medical professionals note that off-label use is common in many fields. The key is informed consent. Patients should understand potential benefits and risks, and know that evidence is still developing for TMD.
Specialists also stress technique. Accurate placement can reduce chewing weakness and facial asymmetry. Clinicians may start with lower doses and adjust over time. Follow-up is important to track results and any adverse effects.
Because Althoff previously had a poor outcome, her decision to try again highlights a frequent scenario. Patients who respond poorly once may seek a second opinion, a different dose, or an alternative provider. Others opt for non-injection care, including splints, stress management, and jaw exercises.
Public Health Context
TMD affects millions of Americans, with estimates often in the single-digit percentage range of adults. Women seek care more frequently than men. Pain and sleep problems are common drivers for treatment.
As social media influencers discuss health experiences, their stories can spread quickly. These posts can help people ask better questions, but they can also oversimplify care decisions. Althoff’s account adds to that conversation, showing both the appeal and the trade-offs of treatment.
Althoff’s update underscores a careful message: results vary, and side effects are possible even when treatment aims to reduce pain. For those considering jaw injections, clinicians recommend a thorough evaluation, a clear set of goals, and a plan for follow-up care. The next few weeks may show whether her symptoms ease as the drug takes effect. More broadly, expect patient interest in off-label solutions to continue, along with calls for stronger evidence and better guidance.
